BRIEF-AstraZeneca Says Lokelma Label Update Approved In China For Patients With Hyperkalaemia On Chronic Haemodialysis
25 Nov 2020 / 04:27 H.
Nov 24 (Reuters) - AstraZeneca PLC:
* LOKELMA LABEL UPDATE APPROVED IN CHINA FOR PATIENTS WITH HYPERKALAEMIA ON CHRONIC HAEMODIALYSIS
* NMPA HAS APPROVED DOSING LABEL UPDATE IN CHINA FOR CO'S LOKELMA TO INCLUDE PATIENTS WITH HYPERKALAEMIA ON CHRONIC HAEMODIALYSIS Source text : (https://bit.ly/372REjG) Further company coverage:
Did you like this article?
